A comprehensive view of liver / kidney / bladder health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Creatinine test market forecast to grow from 2024 value of US$1250.4M to US$6212.9M by 2034, grow at CAGR of 17.4%; growth driven by increasing incidence of chronic kidney diseases worldwide, increasing awareness of kidney health: Prophecy Market Insights

Gilead Sciences to purchase CymaBay Therapeutics for US$4.3B to expand its liver disease portfolio; deal give Gilead access to Seladelpar, a promising drug for the treatment of primary biliary cholangitis slated for potential FDA approval in 2024

Life sciences companies constitute small portion of unitary patent registrations, with J&J leading according to the European Patent Office; medical technology, pharmaceuticals, and biotechnology represent notable portions

Bayer Portugal supports critical study on diabetic renal disease, while Bayer introduces eco-friendly pest resistance solutions for sustainable agriculture

Eli Lilly reports its weight loss drug Tirzepatide significantly reverses metabolic dysfunction-associated steatohepatitis in Phase 2 trial

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count